jay chhablani

[jay chhablani @jaychhablani]

I’m happy to share that I’m starting a new position as Vice Chair, Clinical Trials at Pitt Department of Ophthalmology/UPMC Vision Institute!

[jay chhablani @jaychhablani]

An innovative AI-powered tool for segmenting geographic atrophy (GA) and ellipsoid zone (EZ) loss. This tool enables precise AI-driven segmentation while allowing manual correction, ensuring users can validate each scan for EZ loss and hypertransmission with confidence.

[jay chhablani @jaychhablani]

I am honoured to announce that we have been awarded Thome Foundation grant for our project: "Personalized Assembloid Platform for Drug Discovery and Modelling of Age-Related Macular Degeneration."

[Choroid Analysis Research Lab @CARLabChoroid]

Recent publication on 3D choroidal contour in healthy eyes and the effect with aging. Congratulations team!!
#UPMC #CARLab #Choroid #OCT

https://t.co/ixkOBULguv

[jay chhablani @jaychhablani]

@SiddharthSane @aao_ophth @OphthoMag @RetinaToday @RetinaGlobal1 @RetinalPhys @ERSjournal @UPMC @eyeandear @DiabetesHealth @NIHClinicalCntr Very few subjects in that subgroup in US clinical trials, therefore, they are put together as Asian.

[jay chhablani @jaychhablani]

How is the racial distribution in our clinical trials? Our recent study published in Ophthalmology Retina shows "Black, Asian, and Hispanic patients remain significantly underrepresented among the DME clinical trial patient population based on diabetes prevalence."

[Brilliantly AI @BrilliantlyAI]

We're excited to announce SightBot 👁️🤖, a #ChatGPT-powered chatbot you can chat with about biomedical research topics and receive responses with PubMed citations! Built on @langchain.
https://t.co/DustOuDVcW

[Brilliantly AI @BrilliantlyAI]

Last, but not least, a special thanks to our amazing collaborators: SightBot was made in partnership with Nikita Kedia and @jaychhablani of the University of Pittsburgh!

[jay chhablani @jaychhablani]

Our work on "Volumetric choroidal vessel segmentation" just got published after hard work for 3 years. Kudos to Mohammed Nasar Ibrahim (first author) and Kiran Vupparaboina, who leads our AI work @ChoroidalAnalysis&Research (CAR) Lab.

[jay chhablani @jaychhablani]

so glad to be here at #arvo2022 ....18 presentations....12 abstracts from our "CAR (Choroid Analysis Research) Lab"....Thanks to the amazing team...#Ophthalmology #upmc

[Expertscape: Your Source For Medical Experts @Daily_Experts]

During AMD/Low Vision Awareness Month (February 2021), we congratulate Dr. Jay Kumar Chhablani of the University of Pittsburgh -- Recognized as an Expertscape Expert in Macular Edema.
https://t.co/AYf48cSpxd

[jay chhablani @jaychhablani]

@kennethcole

[jay chhablani @jaychhablani]

Happy Holidays @kennethcole

[jay chhablani @jaychhablani]

@EURETINA @AmJOphthalmol @OphthoMag @aao_ophth @APAOphth
Dr Jay Chhablani honoured with #VRSI Vitreo Retina Society of India's inaugural Namperumalsamy Young Researcher Award at their annual #conference in #Jaipur. Dr Chhablani's talk was on Choroidal Imaging Biomarkers

[LVPEI @lvprasadeye]

Dr Jay Chhablani honoured with #VRSI Vitreo Retina Society of India's inaugural Namperumalsamy Young Researcher Award at their annual #conference in #Jaipur 30 Nov-2 Dec. Dr Chhablani's talk was on Choroidal Imaging Biomarkers

[jay chhablani @jaychhablani]

@lvprasadeye @AmJOphthalmol @APAOphth #ophthalmology

[jay chhablani @jaychhablani]

@lvprasadeye @AmJOphthalmol @APAOphth

[jay chhablani @jaychhablani]

@lvprasadeye #ophthalmology

[LVPEI @lvprasadeye]

Dr Jay Kumar Chhablani has been invited to join the editorial board of American Journal of Ophthalmology.

[jay chhablani @jaychhablani]

Delivered a talk on ‘Landmark Achievements in Choroidal Diseases’ at International Council of Ophthalmology's World Ophthalmology Congressin Barcelona on June 17, at WOC Day of Landmark Achievements III (2016-2018). #ophthalmology #retina #WOC2018